Transforming a new drug from a set of liquid ingredients in a lab to a pill in a box can be an exercise in complex chemistry. To better understand how drug ingredients crystallize, UConn researchers mined a vast collection of experimental data provided by Pfizer. They reported their findings in the Feb. 28 cover story of the journal CrystEngComm.